Ohr Pharmaceutical Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
56.47 M |
Public Float |
51.43 M |
Ohr Pharmaceutical Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.17 |
Market Cap |
$10.47 M |
Shares Outstanding |
2.83 M |
Public Float |
2.69 M |
Address |
800 Third Avenue New York New York 10022 United States |
Employees | - |
Website | http://www.ohrpharmaceutical.com |
Updated | 07/08/2019 |
Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B. |